The studies, which provide new results from two clinical trials, compared the effects of semaglutide versus placebo in reducing heart failure-related symptoms, physical limitations, weight and heart failure hospitalizations in patients with obesity and heart failure with preserved ejection fraction, or HFpEF
At this time early research in general shows the plus side of these medications outweighs some potential side effects. In this The risk of diabetic retinopathy came with the results of the SUSTAIN 6 trial, the first that compared the effect of semaglutide in cardiovascular outcomes in subjects with type 2 diabetes, Fernando Gerchman, MD, PhD, professor of medicine in the Division of Endocrinology and Metabolism at the Hospital de Clnicas de Porto Alegre in Brazil and senior author of this study, told MNT
These medications mimic the natural GLP-1 hormone in the body, offering a range of benefits for weight loss and metabolic health
If you have any concerns about your general health, you should contact your local healthcare provider
(2006) Effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling, Circulation, Vol
